{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:18:12Z","timestamp":1791494292108,"version":"4.3.4"},"reference-count":107,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,2]]},"DOI":"10.1093\/jcag\/gwy056","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T16:13:32Z","timestamp":1540916012000},"page":"S49-S67","source":"Crossref","is-referenced-by-count":117,"title":["The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD"],"prefix":"10.1093","volume":"2","author":[{"given":"Matthew W","family":"Carroll","sequence":"first","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-8426","authenticated-orcid":false,"given":"M Ellen","family":"Kuenzig","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"Children\u2019s Hospital of Eastern Ontario IBD Centre, Department of Pediatrics and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Mack","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"Children\u2019s Hospital of Eastern Ontario IBD Centre, Department of Pediatrics and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R","family":"Otley","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"Division of Gastroenterology and Nutrition, Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"SickKids IBD Centre, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilaad G","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"Department of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"University of Manitoba IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bitton","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"McGill IBD Centre of Excellence, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K","family":"Murthy","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"Ottawa Hospital Research Institute, Department of Medicine and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey C","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"Mount Sinai Hospital Centre for IBD, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Lee","sequence":"additional","affiliation":[{"name":"Crohn\u2019s and Colitis Canada, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Cooke-Lauder","sequence":"additional","affiliation":[{"name":"Bataleur Enterprises Inc., Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-3598","authenticated-orcid":false,"given":"Eric I","family":"Benchimol","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium Ottawa, Canada"},{"name":"Children\u2019s Hospital of Eastern Ontario IBD Centre, Department of Pediatrics and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"issue":"10","key":"2019042409563213300_CIT0001","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/MIB.0000000000000103","article-title":"Changing age demographics of inflammatory bowel disease in Ontario, Canada: A population-based cohort study of epidemiology trends","volume":"20","author":"Benchimol","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"2019042409563213300_CIT0002","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ibd.21349","article-title":"Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends","volume":"17","author":"Benchimol","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"2019042409563213300_CIT0003","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/j.gastro.2014.06.023","article-title":"Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease","volume":"147","author":"Benchimol","year":"2014","journal-title":"Gastroenterology"},{"issue":"9","key":"2019042409563213300_CIT0004","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ajg.2017.208","article-title":"Rural and urban residence during early life is associated with risk of inflammatory bowel disease: A population-based inception and birth cohort study","volume":"112","author":"Benchimol","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"2019042409563213300_CIT0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tig.2017.06.008","article-title":"Clinical genomics in inflammatory bowel disease","volume":"33","author":"Uhlig","year":"2017","journal-title":"Trends Genet"},{"issue":"5","key":"2019042409563213300_CIT0006","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1053\/j.gastro.2015.08.001","article-title":"Genetics of inflammatory bowel diseases","volume":"149","author":"McGovern","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"2019042409563213300_CIT0007","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2014.07.023","article-title":"The diagnostic approach to monogenic very early onset inflammatory bowel disease","volume":"147","author":"Uhlig","year":"2014","journal-title":"Gastroenterology"},{"issue":"10080","key":"2019042409563213300_CIT0008","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0140-6736(17)30317-3","article-title":"Prediction of complicated disease course for children newly diagnosed with Crohn\u2019s disease: A multicentre inception cohort study","volume":"389","author":"Kugathasan","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"1","key":"2019042409563213300_CIT0009","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","article-title":"Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease","volume":"67","author":"Imhann","year":"2018","journal-title":"Gut"},{"issue":"2","key":"2019042409563213300_CIT0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.gastro.2016.10.012","article-title":"Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches","volume":"152","author":"Sartor","year":"2017","journal-title":"Gastroenterology"},{"issue":"11","key":"2019042409563213300_CIT0011","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/ajg.2014.246","article-title":"Antibiotics associated with increased risk of new-onset Crohn\u2019s disease but not ulcerative colitis: A meta-analysis","volume":"109","author":"Ungaro","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2019042409563213300_CIT0012","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn\u2019s disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"key":"2019042409563213300_CIT0013","doi-asserted-by":"crossref","first-page":"no pagination","DOI":"10.1038\/ncomms13419","article-title":"Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn\u2019s disease","volume":"7","author":"Mottawea","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"2019042409563213300_CIT0014","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11894-013-0326-4","article-title":"The role of the environment in the development of pediatric inflammatory bowel disease","volume":"15","author":"Aujnarain","year":"2013","journal-title":"Curr Gastroenterol Rep"},{"issue":"46","key":"2019042409563213300_CIT0015","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.3748\/wjg.v13.i46.6134","article-title":"Smoking in inflammatory bowel diseases: Good, bad or ugly","volume":"13","author":"Lakatos","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2019042409563213300_CIT0016","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ibd.20070","article-title":"Active and passive smoking in childhood is related to the development of inflammatory bowel disease","volume":"13","author":"Mahid","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2019042409563213300_CIT0017","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ebiom.2017.06.012","article-title":"The NOD2-smoking interaction in Crohn\u2019s disease is likely specific to the 1007fs mutation and may be explained by age at diagnosis: A meta-analysis and case-only study","volume":"21","author":"Kuenzig","year":"2017","journal-title":"EBioMedicine"},{"issue":"11","key":"2019042409563213300_CIT0018","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/ajg.2010.252","article-title":"The inflammatory bowel diseases and ambient air pollution: A novel association","volume":"105","author":"Kaplan","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2019042409563213300_CIT0019","doi-asserted-by":"crossref","DOI":"10.4161\/gmic.27251","article-title":"Air pollution effects on the gut microbiota: A link between exposure and inflammatory disease","volume":"5","author":"Salim","year":"2014","journal-title":"Gut Microbes"},{"issue":"7","key":"2019042409563213300_CIT0020","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/MIB.0000000000000066","article-title":"Exposure to ingested airborne pollutant particulate matter increases mucosal exposure to bacteria and induces early onset of inflammation in Neonatal IL-10-deficient mice","volume":"20","author":"Salim","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"2019042409563213300_CIT0021","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1572-0241.2006.00381.x","article-title":"A population-based case control study of potential risk factors for IBD","volume":"101","author":"Bernstein","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"2019042409563213300_CIT0022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-230X-12-51","article-title":"The relationship between urban environment and the inflammatory bowel diseases: A systematic review and meta-analysis","volume":"12","author":"Soon","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"2019042409563213300_CIT0023","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1542\/peds.2006-3624","article-title":"Contact with farm animals in early life and juvenile inflammatory bowel disease: A case-control study","volume":"120","author":"Radon","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"2019042409563213300_CIT0024","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.dld.2011.10.001","article-title":"Diet and risk of inflammatory bowel disease","volume":"44","author":"Andersen","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"4","key":"2019042409563213300_CIT0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: A systematic review of the literature","volume":"106","author":"Hou","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2019042409563213300_CIT0026","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/ajcn\/80.5.1342","article-title":"Breastfeeding and risk of inflammatory bowel disease: A systematic review with meta-analysis","volume":"80","author":"Klement","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2019042409563213300_CIT0027","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jpeds.2009.03.017","article-title":"Systematic review: The role of breastfeeding in the development of pediatric inflammatory bowel disease","volume":"155","author":"Barclay","year":"2009","journal-title":"J Pediatr"},{"issue":"17","key":"2019042409563213300_CIT0028","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.3748\/wjg.v20.i17.4934","article-title":"Vitamin D improves inflammatory bowel disease outcomes: Basic science and clinical review","volume":"20","author":"Reich","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2019042409563213300_CIT0029","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1074\/jbc.C109.071225","article-title":"Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2\/CARD15-defensin beta2 innate immune pathway defective in Crohn\u2019s disease","volume":"285","author":"Wang","year":"2010","journal-title":"J Biol Chem"},{"issue":"59","key":"2019042409563213300_CIT0030","first-page":"325","article-title":"vitamin D receptor, and macroautophagy in inflammation and infection","volume":"11","author":"Wu","year":"2011","journal-title":"Discov Med"},{"issue":"1","key":"2019042409563213300_CIT0031","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1741-7015-10-69","article-title":"Month of birth, vitamin D and risk of immune mediated disease: A case control study","volume":"10","author":"Disanto","year":"2012","journal-title":"BMC Med"},{"issue":"12","key":"2019042409563213300_CIT0032","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1038\/ajg.2010.398","article-title":"Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease","volume":"105","author":"Shaw","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"2019042409563213300_CIT0033","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/ajg.2011.304","article-title":"Association between the use of antibiotics and new diagnoses of Crohn\u2019s disease and ulcerative colitis","volume":"106","author":"Shaw","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2019042409563213300_CIT0034","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jpeds.2012.08.037","article-title":"Association between early childhood otitis media and pediatric inflammatory bowel disease: An exploratory population-based analysis","volume":"162","author":"Shaw","year":"2013","journal-title":"J Pediatr"},{"issue":"1","key":"2019042409563213300_CIT0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cgh.2013.06.027","article-title":"Younger age at diagnosis is associated with panenteric, but not more aggressive, Crohn\u2019s disease","volume":"12","author":"Israeli","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2019042409563213300_CIT0036","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.gastro.2008.06.081","article-title":"Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease","volume":"135","author":"Limbergen","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"2019042409563213300_CIT0037","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jpeds.2010.11.039","article-title":"Outcomes of pediatric inflammatory bowel disease: Socioeconomic status disparity in a universal-access healthcare system","volume":"158","author":"Benchimol","year":"2011","journal-title":"J Pediatr"},{"issue":"7","key":"2019042409563213300_CIT0038","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cgh.2015.01.022","article-title":"Health care use by a population-based cohort of children with inflammatory bowel disease","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"2019042409563213300_CIT0039","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ajg.2012.127","article-title":"The epidemiology of colectomy in ulcerative colitis: Results from a population-based cohort","volume":"107","author":"Targownik","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"2019042409563213300_CIT0040","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1097\/MIB.0b013e3182a56148","article-title":"Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009","volume":"19","author":"deBruyn","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"2019042409563213300_CIT0041","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1053\/j.gastro.2010.02.047","article-title":"Severe pediatric ulcerative colitis: A prospective multicenter study of outcomes and predictors of response","volume":"138","author":"Turner","year":"2010","journal-title":"Gastroenterology"},{"issue":"11","key":"2019042409563213300_CIT0042","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1007\/s00198-017-4159-0","article-title":"Musculoskeletal health in newly diagnosed children with Crohn\u2019s disease","volume":"28","author":"Ward","year":"2017","journal-title":"Osteoporosis Int"},{"issue":"10","key":"2019042409563213300_CIT0043","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/ibd.21591","article-title":"Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994\u20132007)","volume":"17","author":"Benchimol","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"2019042409563213300_CIT0044","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","article-title":"Direct health care costs of Crohn\u2019s disease and ulcerative colitis in US children and adults","volume":"135","author":"Kappelman","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"2019042409563213300_CIT0045","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.cgh.2014.02.042","article-title":"Factors associated with readmissions and outcomes of patients hospitalized for inflammatory bowel disease","volume":"12","author":"Nguyen","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019042409563213300_CIT0046","doi-asserted-by":"crossref","first-page":"no pagination","DOI":"10.1155\/2017\/7365937","article-title":"Public versus private drug insurance and outcomes of patients requiring biologic therapies for inflammatory bowel disease","volume":"2017","author":"Rumman","year":"2017","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2019042409563213300_CIT0047","doi-asserted-by":"crossref","first-page":"no pagination","DOI":"10.1155\/2016\/9430942","article-title":"The challenges of living with inflammatory bowel disease: Summary of a summit on patient and health care provider perspectives","volume":"2016","author":"Bray","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"8","key":"2019042409563213300_CIT0048","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/ecco-jcc\/jjx036","article-title":"Quality items required for running a paediatric inflammatory bowel disease centre: An ECCO paper","volume":"11","author":"Turner","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2019042409563213300_CIT0049","doi-asserted-by":"crossref","first-page":"no pagination","DOI":"10.1155\/2017\/3676474","article-title":"Allied health professional support in pediatric inflammatory bowel disease: A survey from the Canadian children inflammatory bowel disease network - a joint partnership of CIHR and the CH.I.L.D. Foundation","volume":"2017","author":"El-Matary","year":"2017","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2019042409563213300_CIT0050","first-page":"520","article-title":"Crohn\u2019s Disease","volume-title":"Pediatric Gastrointestinal and Liver Disease, Fifth Edition","author":"Wilson","year":"2015"},{"key":"2019042409563213300_CIT0051","doi-asserted-by":"crossref","first-page":"j2083","DOI":"10.1136\/bmj.j2083","article-title":"Diagnosis and management of inflammatory bowel disease in children","volume":"357","author":"Oliveira","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"2019042409563213300_CIT0052","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MPG.0000000000001024","article-title":"Use of placebo in pediatric inflammatory bowel diseases: A position paper from ESPGHAN, ECCO, PIBDnet, and the Canadian children IBD network","volume":"62","author":"Turner","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"2019042409563213300_CIT0053","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MPG.0b013e318175ca7f","article-title":"Growth abnormalities persist in newly diagnosed children with Crohn\u2019s disease despite current treatment paradigms","volume":"48","author":"Pfefferkorn","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"2019042409563213300_CIT0054","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","article-title":"Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease","volume":"8","author":"Ruemmele","year":"2014","journal-title":"J Crohn\u2019s Colitis"},{"issue":"4","key":"2019042409563213300_CIT0055","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0016-5085(98)70251-3","article-title":"Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease","volume":"115","author":"Kirschner","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"2019042409563213300_CIT0056","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/j.gastro.2013.07.035","article-title":"Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: A nationwide retrospective cohort study","volume":"145","author":"Khan","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"2019042409563213300_CIT0057","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2010.09.016","article-title":"A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease","volume":"9","author":"Kotlyar","year":"2011","journal-title":"Clin Gastroenterol H"},{"issue":"8","key":"2019042409563213300_CIT0058","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ibd.20169","article-title":"Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn\u2019s disease: A cautionary tale","volume":"13","author":"Rosh","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"2019042409563213300_CIT0059","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/gutjnl-2011-301133","article-title":"Inflammatory bowel disease therapies and cancer risk: Where are we and where are we going","volume":"61","author":"Beaugerie","year":"2012","journal-title":"Gut"},{"issue":"8","key":"2019042409563213300_CIT0060","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1053\/j.gastro.2017.02.004","article-title":"Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease","volume":"152","author":"Hyams","year":"2017","journal-title":"Gastroenterology"},{"issue":"9","key":"2019042409563213300_CIT0061","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.cgh.2014.01.021","article-title":"Risks of serious infection or lymphoma with anti-tumor necrosis-factor therapy for pediatric inflammatory bowel disease: A systematic review","volume":"12","author":"Dulai","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"2019042409563213300_CIT0062","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ibd.20089","article-title":"Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease","volume":"13","author":"Bernstein","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"13","key":"2019042409563213300_CIT0063","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2165\/00002018-200124130-00001","article-title":"Measles vaccination and inflammatory bowel disease: Controversy laid to rest","volume":"24","author":"Davis","year":"2001","journal-title":"Drug Saf"},{"issue":"3","key":"2019042409563213300_CIT0064","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archpedi.155.3.354","article-title":"Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: A case-control study from the vaccine safety datalink project","volume":"155","author":"Davis","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"2019042409563213300_CIT0065","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/ecco-jcc\/jjv029","article-title":"Early childhood measles vaccinations are not associated with paediatric IBD: A population-based analysis","volume":"9","author":"Shaw","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"8","key":"2019042409563213300_CIT0066","first-page":"65","article-title":"Does measles-mumps-rubella (MMR) vaccination cause inflammatory bowel disease and autism","volume":"27","author":"Strauss","year":"2001","journal-title":"Can Commun Dis Rep"},{"issue":"8","key":"2019042409563213300_CIT0067","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.cgh.2015.04.179","article-title":"Vaccination and risk for developing inflammatory bowel disease: A meta-analysis of case-control and cohort studies","volume":"13","author":"de Chambrun","year":"2015","journal-title":"Clin Gastroenterol H"},{"issue":"6","key":"2019042409563213300_CIT0068","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/infdis\/jis923","article-title":"Largest measles epidemic in North America in a Decade-Quebec, Canada, 2011: Contribution of susceptibility, serendipity, and superspreading events","volume":"207","author":"De Serres","year":"2013","journal-title":"J Infect Dis"},{"issue":"11","key":"2019042409563213300_CIT0069","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jama.2016.1353","article-title":"Association between vaccine refusal and vaccine-preventable diseases in the United States a review of measles and pertussis","volume":"315","author":"Phadke","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"2019042409563213300_CIT0070","doi-asserted-by":"crossref","first-page":"e1811","DOI":"10.1542\/peds.2012-3567","article-title":"Safety and utilization of influenza immunization in children with inflammatory bowel disease","volume":"131","author":"Benchimol","year":"2013","journal-title":"Pediatrics"},{"issue":"29","key":"2019042409563213300_CIT0071","first-page":"620","article-title":"Human papillomavirus vaccination coverage among adolescents, 2007\u20132013, and postlicensure vaccine safety monitoring, 2006\u20132014-United States","volume":"63","author":"Stokley","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2019042409563213300_CIT0072","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ibd.21706","article-title":"Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease","volume":"18","author":"deBruyn","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"2019042409563213300_CIT0073","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/MIB.0000000000000425","article-title":"Strategies to improve influenza vaccination in pediatric inflammatory bowel disease through education and access","volume":"21","author":"Huth","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"2019042409563213300_CIT0074","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2019042409563213300_CIT0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG clinical guideline: Preventive care in inflammatory bowel disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2019042409563213300_CIT0076","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jinf.2017.02.009","article-title":"Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease","volume":"74","author":"Mazzola","year":"2017","journal-title":"J Infection"},{"issue":"8","key":"2019042409563213300_CIT0077","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"2019042409563213300_CIT0078","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/ctg.2016.8","article-title":"Anal neoplasia in inflammatory bowel disease is associated with HPV and perianal disease","volume":"7","author":"Ruel","year":"2016","journal-title":"Clin Transl Gastroen"},{"issue":"8","key":"2019042409563213300_CIT0079","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/ecco-jcc\/jjx035","article-title":"Anal neoplasia in inflammatory bowel disease: Classification proposal, epidemiology, carcinogenesis, and risk management perspectives","volume":"11","author":"Wisniewski","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2019042409563213300_CIT0080","volume-title":"Canadian Immunization Guide. Part 3: Vaccination of Specific Populations","author":"Government of Canada","year":"2016"},{"issue":"45","key":"2019042409563213300_CIT0081","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1016\/j.vaccine.2017.09.031","article-title":"Vaccination strategies in pediatric inflammatory bowel disease","volume":"35","author":"Dipasquale","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"2019042409563213300_CIT0082","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MPG.0b013e31824d1438","article-title":"Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD porto group commentary","volume":"54","author":"Veereman-Wauters","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019042409563213300_CIT0083","volume-title":"Canadian Immunization Guide. Part 3: Vaccination of Specific Populations. Page 8 Immunization of Immunocompromised Persons","author":"Government of Canada","year":"2016"},{"issue":"5","key":"2019042409563213300_CIT0084","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338","article-title":"Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? a meta-analysis","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"2019042409563213300_CIT0085","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MPG.0000000000000850","article-title":"School attendance in children with functional abdominal pain and inflammatory bowel diseases","volume":"61","author":"Assa","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"2019042409563213300_CIT0086","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jpeds.2014.12.010","article-title":"Academic performance among children with inflammatory bowel disease: A population-based study","volume":"166","author":"Singh","year":"2015","journal-title":"J Pediatr"},{"issue":"5","key":"2019042409563213300_CIT0087","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/ibd.21464","article-title":"Assessment of knowledge in adolescents with inflammatory bowel disease using a novel transition tool","volume":"17","author":"Benchimol","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2019042409563213300_CIT0088","first-page":"S354","article-title":"Health services utilization in adolescents with inflammatory bowel disease transitioning from pediatric to adult care: A population-based cohort study","volume":"63(Suppl 2)","author":"Zhao","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"2019042409563213300_CIT0089","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2165\/00019053-199916060-00002","article-title":"Measuring quality of life in paediatric patients","volume":"16","author":"Connolly","year":"1999","journal-title":"PharmacoEconomics"},{"key":"2019042409563213300_CIT0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1008801802877","article-title":"The proxy problem: Child report versus parent report in health-related quality of life research","volume":"7","author":"Theunissen","year":"1998","journal-title":"Qual Life Res"},{"issue":"4","key":"2019042409563213300_CIT0091","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta5040","article-title":"Quality-of-life measures in chronic diseases of childhood","volume":"5","author":"Eiser","year":"2001","journal-title":"Health Technol Assess"},{"issue":"4","key":"2019042409563213300_CIT0092","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jclp.1029","article-title":"Quality of life measurements in children and adolescents: Issues, instruments, and applications","volume":"57","author":"Wallander","year":"2001","journal-title":"J Clin Psychol"},{"key":"2019042409563213300_CIT0093","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0021-9681(87)80039-5","article-title":"Measuring the impact of medical care on children","volume":"40","author":"Pantell","year":"1987","journal-title":"J Chronic Dis"},{"issue":"4","key":"2019042409563213300_CIT0094","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/MPG.0000000000001549","article-title":"Psychological distress and quality of life in pediatric Crohn disease: Impact of pain and disease state","volume":"65","author":"Claar","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"2019042409563213300_CIT0095","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1097\/MIB.0b013e3182a82b15","article-title":"The clinical utility of health-related quality of life screening in a pediatric inflammatory bowel disease clinic","volume":"19","author":"Ryan","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"2019042409563213300_CIT0096","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jpeds.2009.11.008","article-title":"Health-related quality of life across pediatric chronic conditions","volume":"156","author":"Ingerski","year":"2010","journal-title":"J Pediatr"},{"issue":"11","key":"2019042409563213300_CIT0097","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1440-1754.2011.02034.x","article-title":"Health-related quality of life in paediatric patients with inflammatory bowel disease related to disease activity","volume":"47","author":"Haapamaki","year":"2011","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"2019042409563213300_CIT0098","first-page":"Cd009660","article-title":"Psychological interventions for parents of children and adolescents with chronic illness","volume":"2015","author":"Eccleston","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2019042409563213300_CIT0099","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jpepsy\/jsn056","article-title":"Parent quality of life in the context of pediatric inflammatory bowel disease","volume":"34","author":"Greenley","year":"2009","journal-title":"J Pediatr Psychol"},{"issue":"4","key":"2019042409563213300_CIT0100","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/00005176-199904001-00007","article-title":"Quality of life of parents and siblings of children with inflammatory bowel disease","volume":"28","author":"Akobeng","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"2019042409563213300_CIT0101","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00005176-199612000-00003","article-title":"Quality of life in children with Crohn\u2019s disease","volume":"23","author":"Rabbett","year":"1996","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"2019042409563213300_CIT0102","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1399-5448.2002.30303.x","article-title":"Correlates of depressive symptoms in adolescents with type 1 diabetes","volume":"3","author":"Whittemore","year":"2002","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"2019042409563213300_CIT0103","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/MPG.0000000000000696","article-title":"Health-related quality of life in youth with Crohn disease: Role of disease activity and parenting stress","volume":"60","author":"Gray","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"2019042409563213300_CIT0104","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MEG.0b013e3283417abb","article-title":"Family functioning and health-related quality of life in adolescents with pediatric inflammatory bowel disease","volume":"23","author":"Herzer","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"2019042409563213300_CIT0105","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11136-011-9853-3","article-title":"Maternal, paternal, and family health-related quality of life in the context of pediatric inflammatory bowel disease","volume":"20","author":"Kunz","year":"2011","journal-title":"Qual Life Res"},{"issue":"3","key":"2019042409563213300_CIT0106","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MPG.0b013e3181f5714e","article-title":"Patient and parent psychosocial factors associated with health-related quality of life in pediatric inflammatory bowel disease","volume":"52","author":"Herzer","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019042409563213300_CIT0107","first-page":"275","article-title":"Parental quality of life in the framework of paediatric chronic gastrointestinal disease","volume":"35","author":"Knez","year":"2011","journal-title":"Coll Antropol"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcag\/article-pdf\/2\/Supplement_1\/S49\/28515566\/gwy056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T09:58:38Z","timestamp":1556099918000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/2\/Supplement_1\/S49\/5154762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":107,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2018,11,2]]},"published-print":{"date-parts":[[2019,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwy056","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"value":"2515-2084","type":"print"},{"value":"2515-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,11,2]]}}}